Form 4: SeaStar Medical Director John Neuman Increases Stake with Significant Share Purchase

SeaStar Medical Holding Corp. Director John Neuman purchased 40,000 shares of common stock at a weighted average price of $0.3599, increasing his beneficial ownership to 80,000 shares.

Summary

• John Neuman, a Director of SeaStar Medical Holding Corp. (ICU), acquired 40,000 shares of the company's common stock.
• The transaction occurred on June 24, 2025, and was a purchase (Code 'P').
• The shares were acquired at a weighted average price of $0.3599 per share.
• The purchase involved multiple transactions with prices ranging from $0.359 to $0.36 per share.
• Following this transaction, Mr. Neuman's direct beneficial ownership of SeaStar Medical common stock increased to 80,000 shares.

Sentiment

Score: 7

Explanation: The sentiment is positive due to a director's purchase of company shares, indicating confidence in the company's value. However, the low share price at which the transaction occurred could suggest underlying challenges or a depressed market valuation.

Positives

• The purchase by a Director signals confidence in the company's future prospects and valuation.
• Increased insider ownership aligns management's interests more closely with those of shareholders.

Negatives

• The low share price of $0.3599 at which the shares were purchased could indicate a depressed valuation or market concerns about the company's performance.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

Insider purchases, such as this one by a director, are often viewed by the market as a positive signal, indicating that those with intimate knowledge of the company believe its stock is undervalued or that positive developments are anticipated. This can be a sign of internal confidence in the company's strategic direction or operational performance within the broader medical technology industry.

Stakeholder Impact

• Shareholders may interpret this insider purchase as a positive indicator of management's belief in the company's future, potentially boosting investor confidence.
• Employees may view this as a sign of stability and positive internal outlook.

Key Dates

Keywords

SeaStar Medical Holding Corp, ICU, John Neuman, Insider Trading, Form 4, Share Purchase, Director, Beneficial Ownership, Equity Acquisition